DelveInsight has launched a new report on “Respiratory Syncytial Virus (RSV)-Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Respiratory Syncytial Virus (RSV)–Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Respiratory Syncytial Virus (RSV), historical and forecasted epidemiology as well as the Respiratory Syncytial Virus (RSV) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Report:
-
A study, wherein RSV was detected in 7% of hospitalized individuals. The highest prevalence was found in the age group 50−64 (8.7%), and 98% of RSV cases in this age group had at least one chronic comorbidity.
-
As per a study in a cohort of patients suffering from acute respiratory tract infection (ARI), RSV accounted for 1–10% in adults and 2–14% in patients with chronic diseases or transplantation.
-
A study that estimated that 2% of patients infected with RSV in the age
Key benefits of the report:
1.The Respiratory Syncytial Virus (RSV) market report covers a descriptive overview and comprehensive insight of the Respiratory Syncytial Virus (RSV) epidemiology and Respiratory Syncytial Virus (RSV) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2.The Respiratory Syncytial Virus (RSV) market report provides insights into the current and emerging therapies.
3.Respiratory Syncytial Virus (RSV) market report provides a global historical and forecasted market covering drug outreach in 7MM.
4.The Respiratory Syncytial Virus (RSV) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Respiratory Syncytial Virus (RSV) market.
Request for sample pages: https://www.delveinsight.com/sample-request/respiratory-syncytial-virus-rsv-market
Respiratory Syncytial Virus (RSV): Overview
Respiratory syncytial virus (RSV) is a highly contagious virus that affects the respiratory system. It is classified as a member of the genus Pneumovirus in the family Paramyxoviridae. Virus particles are enveloped and pleomorphic, occurring as irregular spherical particles that are 100–350 nm in diameter and as long filamentous fibers that are 60–200 nm in diameter and 10 mm in length.
The key players involved in the Respiratory Syncytial Virus (RSV) market:
-
Enanta Pharmaceuticals
-
Janssen Research & Development
-
ReViral
The launch of the emerging therapies is expected to significantly impact the Respiratory Syncytial Virus (RSV) treatment scenario in the upcoming years:-
Drug covered
-
EDP-938
-
JNJ53718678
-
RV521
Request a free sample report @https://www.delveinsight.com/sample-request/respiratory-syncytial-virus-rsv-market
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Respiratory Syncytial Virus (RSV) Patient Share (%) Overview at a Glance
5. Respiratory Syncytial Virus (RSV) Market Overview at a Glance
6. Respiratory Syncytial Virus (RSV) Disease Background and Overview
7. Respiratory Syncytial Virus (RSV) Epidemiology and Patient Population
8. Country-Specific Patient Population of Respiratory Syncytial Virus (RSV)
9. Respiratory Syncytial Virus (RSV) Current Treatment and Medical Practices
10. Unmet Needs
11. Respiratory Syncytial Virus (RSV) Emerging Therapies
12. Respiratory Syncytial Virus (RSV) Market Outlook
13. Country-Wise Respiratory Syncytial Virus (RSV) Market Analysis (2017–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Respiratory Syncytial Virus (RSV) Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Respiratory Syncytial Virus (RSV)-Pipeline Insights, 2021
“Respiratory Syncytial Virus (RSV)-Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Respiratory Syncytial Virus (RSV) market. A detailed picture of the Respiratory Syncytial Virus (RSV) pipeline landscape is provided, which includes the disease overview and Respiratory Syncytial Virus (RSV) treatment guidelines.
Respiratory Syncytial Virus (RSV)-Epidemiology Forecast to 2030
DelveInsight’s ‘Respiratory Syncytial Virus (RSV)-Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Respiratory Syncytial Virus (RSV) {;l epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/